National Bank of Canada
CSCI

National Bank of Canada’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

National Bank of Canada’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,149
Closed -$3.8K – 3276
2025
Q2 		$3.8K Buy
1,149
+27
+2% +$90 ﹤0.01% 2544
2025
Q1 		$2.87K Sell
1,122
-4,798
-81% -$14.1K ﹤0.01% 2461
2024
Q4 		$15.9K Buy
5,920
+124
+2% +$404 ﹤0.01% 2228
2024
Q3 		$21.7K Buy
5,796
+4,952
+587% +$25.1K ﹤0.01% 1923
2024
Q2 		$3.95K Buy
+844
New +$6.43K ﹤0.01% 2311
2024
Q1 		– Sell
-77
Closed -$582 – 2941
2023
Q4 		$582 Sell
77
-10
-11% -$74 ﹤0.01% 2584
2023
Q3 		$817 Hold
87
– – ﹤0.01% 2612
2023
Q2 		$843 Sell
87
-32
-27% -$365 ﹤0.01% 2573
2023
Q1 		$1.18K Hold
119
– – ﹤0.01% 2510
2022
Q4 		$1.43K Hold
119
– – ﹤0.01% 2544
2022
Q3 		$2K Hold
119
– – ﹤0.01% 2547
2022
Q2 		$2K Hold
119
– – ﹤0.01% 2638
2022
Q1 		$4K Hold
119
– – ﹤0.01% 2616
2021
Q4 		$4K Buy
+119
New +$6.27K ﹤0.01% 2597

Other funds holding CSCI

TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

National Bank of Canada's CSCI Position: Q3 2025 in Review

National Bank of Canada sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 1,149 shares — an estimated $3.8K sold.

National Bank of Canada first reported a position in CSCI in Q4 2021 and held it in 14 quarters. The position peaked at $21.7K in Q3 2024. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

  • National Bank of Canada reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 1,149 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $3.8K.
  • National Bank of Canada first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2021 and held it in 14 quarters.
  • National Bank of Canada's COSCIENS Biopharma Inc. Common Stock position peaked at $21.7K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.